Ask a Question

You visited our site and still have questions? Feel free to contact us

Consultation and guidance given not in the framework of service does not serve as a replacement for a physician’s examination or consultation, and is not considered a “medical diagnosis” or “medical opinion". In all cases of urgency, distress or emergency (physical and/or mental), seek medical care with a family doctor, closest emergency room, and/or ambulatory service.   

Start service


Terms of use

Medix FTP Service (the "Service") is designed to provide you with an easy way to transfer files relevant to the management of your case to Medix Medical Services Europe Limited ("Medix", "we" and "us").


The following terms and conditions together with the Medix Information Security Policy (which may be found at http://medix- (together, the "Terms of Service"), form the agreement between you and us in relation to your use of the Service. You should read the Terms of Service carefully before agreeing to them. If you do not understand any part of the Terms of Services, then please contact us at for further information. You acknowledge and agree that by clicking on the "Upload" button, you are indicating that you accept the Terms of Services and agree to be bound by them.


Using the Service


In order to use the Service, you will be required to log in by submitting your member number which was provided to you by the Medix staff, your name and e-mail address. Once you have logged in, you will be able to upload files to the Service. We will download your files to our system and no copy will be retained on the server used to provide the Service. For detailed upload instructions, please click here.


Protection of your information


We take the safeguarding of your information very seriously. In order to prevent unauthorised access or disclosure of your information we have put in place appropriate physical, electronic and administrative procedures to safeguard and secure the files you upload to the Service. However, no method of transmission over the internet, or method of electronic data storage is 100% secure and while we have put in place appropriate protections, we cannot guarantee the security of information you upload to the Service.


Quality and availability of the Service


While we make reasonable efforts to provide the Service, it is provided "as is" with no representation, guarantee or warranty of any kind as to its availability, functionality, that it will meet your requirements or that it will be free of errors or viruses.


We will not be responsible for any damage to your computer system or the computer system of any third party resulting from your use of the Services where such damage is caused by circumstances which are beyond our reasonable control.


I agree
Start service
Start service

New Screening Quadruples Breast Cancer Detection Rates

By: Dr. S. Rizel

MBI is a promising new technique that may reveal findings missed by regular mammography

Studies from the American Cancer Society have shown that five year breast cancer survival rates plummet from 90% in early stages to 22% in later stages, demonstrating how crucial early detection is. As such, customary guidelines mandate periodic mammograms as well as breast MRI and ultrasounds. The main problem with these methods is the difficulty in identifying tumors in dense breast tissue, which exists in among 50% of women.


This kind of tissue obscures the image, effectively hiding potentially cancerous masses.  Furthermore, studies show that women with dense breast are at a higher risk for breast cancer occurrence.


Molecular Breast Imaging, commonly called MBI, might be the solution that everyone is looking for. The technology itself has been developed by the Mayo Clinic, which recently published the results of a large scale trial which clearly demonstrated its advantages.


So how does MBI work? The mechanism is similar to that used in PET scans. Before the imaging, a certain radiotracer is injected into the subject’s bloodstream. This substance is absorbed by the tumor, causing it to distinctly standout on the imaging itself. Because the growth is shown based on the radioactive tracer, presence of dense breast tissue is much less likely to obstruct the imaging, allowing for more accurate images and higher diagnosis rates.


The trial showing this feature consisted of screening 1,585 women using both a mammography and MBI. The idea was to identify cases in which a tumor was missed by the mammogram and would have gone unnoticed were it not for MBI. The results exceeded everyone’s expectations; MBI identified 3.6 times the amount of invasive cancers as opposed to mammography alone. In total, 21 women out of the control group were diagnosed with breast cancer. Five of the tumors were identified using mammography alone, while 19 were diagnosed using both mammogram and MBI. While the possibility of an unnecessary biopsy was high with MBI, reaching 4%, this figure was still significantly lower than the 8% associated with MRI and Ultrasound imaging.        


MBI however isn’t perfect. Some concerns have been voiced regarding the level of radiation exposure involved with in the injection and imaging process. In addition, the trial has only tested MBI when used in conjunction with regular mammography screening, therefore independent screening still needs to be investigated. While these concerns need to be addressed, trial results are very promising, leading many to believe that MBI is indeed to next generation of breast cancer screening.  

By continuing to use this site you consent to the use of cookies on your device as described in our cookie policy unless you have disabled them. You can change your cookie settings at any time but parts of our site will not function correctly without them.